| Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912) |
|---|
| 01/08/2009 | WO2007131012A9 12-aryl or heteroaryl prostaglandin analogs |
| 01/08/2009 | WO2007123867A3 Stable solutions of prostaglandin and uses of same |
| 01/08/2009 | WO2007118198A8 2-METHYLENE-1α,25-DIHYDROXY-19,21-DINORVITAMIN D3 ANALOGS AND USES THEREOF |
| 01/08/2009 | WO2007117680A3 Methods and compositions for treating bacterial infection |
| 01/08/2009 | WO2007112250A3 Dental appliance cleanser |
| 01/08/2009 | WO2007087026A9 Solid-state form of amg 706 and pharmaceutical compositions thereof |
| 01/08/2009 | WO2007076112A3 Tris-quaternary ammonium salts and methods for modulating neuronal nicotinic acetylcholine receptors |
| 01/08/2009 | WO2007026355A3 Modulators of cell migration and methods of identifying same |
| 01/08/2009 | WO2007024717A3 Agents for preventing and treating disorders involving modulation of the ryr receptors |
| 01/08/2009 | WO2006109312A3 Compositions containing beta 2-glycoprotein i-derived peptides for the prevention and/or treatment of vascular disease |
| 01/08/2009 | WO2006105117A3 Method of treating disorders and conditions using peripherally-restricted antagonists and inhibitors |
| 01/08/2009 | WO2006011148A3 Novel crystalline forms of 6alpha, 9alpha-difluoro-11beta hydroxy-16alpha-methyl-3-oxo-17alpha-propionyloxy-androsta-1,4-diene-17beta-carboxylic acid and processes for preparation thereof |
| 01/08/2009 | US20090012494 Intradermal delivery of biological agents |
| 01/08/2009 | US20090012462 Reversibly gelling polyurethane composition for surgical repair and augmentation |
| 01/08/2009 | US20090012307 Process for the Preparation of 4-(imidazol-1-yl)benzenesulfonamide Derivatives |
| 01/08/2009 | US20090012270 Ox2 receptor homologs |
| 01/08/2009 | US20090012183 Composition comprising polyphenol |
| 01/08/2009 | US20090012182 Crystal forms of O-desmethylvenlafaxine succinate |
| 01/08/2009 | US20090012181 Patch |
| 01/08/2009 | US20090012180 Sustained release oral dosage forms; analgesics |
| 01/08/2009 | US20090012179 Use of Tyrphostins to Stimulate Neurite Outgrowth |
| 01/08/2009 | US20090012178 Benzoxazocines and Their Therapeutic Use |
| 01/08/2009 | US20090012177 Treatment of psychiatric disorders using entacapone, tolcapone and other COMT inhibitor or MB-COMT inhibitor drugs |
| 01/08/2009 | US20090012176 Process for manufacturing entacapone |
| 01/08/2009 | US20090012175 Methods of treating cancer with HDAC inhibitors |
| 01/08/2009 | US20090012173 Method for treatment of nocturia |
| 01/08/2009 | US20090012172 Cosmetic/pharmaceutical compositions comprising retinoids and anti-irritants and treatment of keratinization disorders therewith |
| 01/08/2009 | US20090012171 Novel Compounds, Their Preparation and Use |
| 01/08/2009 | US20090012170 Treatment of symptoms of motor dysfunction |
| 01/08/2009 | US20090012169 Combined use of L-carnitine, acetyle L-carnitine and propionyl L-carnitine for the treatment of oligoasthenoteratospermia |
| 01/08/2009 | US20090012168 Adiponection inducers or secretagogues |
| 01/08/2009 | US20090012167 Omega-3 Fatty Acids and Dyslipidemic Agent for Lipid Therapy |
| 01/08/2009 | US20090012166 Oligomers of Straight-Chain and Unbranched Fatty Acids and Drugs Containing These |
| 01/08/2009 | US20090012165 Pharmaceutical combination of nsaid and prostaglandin compound |
| 01/08/2009 | US20090012164 Pinolenic acid compositions, products made thereof, and methods of making pinolenic acid compositions and products |
| 01/08/2009 | US20090012163 Compositions containing Mg/Zn/F-CaP plus inhibitors of pro-inflammatory cytokines (alpha ketoalkanoic acid compound) for osteoporosis prevention, therapy and treatment of bone diseases |
| 01/08/2009 | US20090012162 Composition for treating or preventing cell degeneration using at least one molecule capable of maintaining adhesion molecule expression reversibility and vascular endothelium actin fibre polymerisation |
| 01/08/2009 | US20090012161 Pharmaceutical composition comprising a beta-3-adrenoceptor agonist and a serotonin and/or norepinephrine reuptake inhibitor |
| 01/08/2009 | US20090012160 such as 15-Ethoxycarbonyl-3,3,14,14-tetramethylpentadecanoyl-L-carnitine, for the treatment of cardiovascular, metabolic and gastrointestinal disorders, inflammation, cancer, anemia, Alzheimer's disease, modulating peroxisome proliferator-activated receptors, as microbiocides and viricides |
| 01/08/2009 | US20090012159 High purity bases of 3,3-diphenylpropylamino monoesters |
| 01/08/2009 | US20090012157 Sesamol Derivatives as Novel Inhibitors of Arachidonic Acid Formation |
| 01/08/2009 | US20090012156 Composition comprising polyphenol |
| 01/08/2009 | US20090012154 Antagonists of the transient receptor potential vanilloid 1 and uses thereof |
| 01/08/2009 | US20090012153 Aminoacid derivatives containing a disulfanyl group in the form of mixed disulfanyl and aminopeptidase n inhibitors |
| 01/08/2009 | US20090012151 Novel Compounds 951 |
| 01/08/2009 | US20090012150 Stablized Pharmaceutical Composition Comprising an Amorphous Active Substance |
| 01/08/2009 | US20090012149 Prodrug of an ice inhibitor |
| 01/08/2009 | US20090012148 Reducing cellular cholesterol levels and/or treating or preventing phospholipidosis |
| 01/08/2009 | US20090012147 2-(4-Chloro-2-oxo-2,3-dihydro-1H-indol-1-yl)acetamide; for treating, ameliorating, or inhibiting the effects of movement disorders and/or motor fluctuations in a subject suffering from Parkinson's disease |
| 01/08/2009 | US20090012146 Solubility-enhanced pharmaceutical compositions comprising zafirlukast |
| 01/08/2009 | US20090012145 Therapeutic esters |
| 01/08/2009 | US20090012142 Compositions and Methods for Increasing Lean Muscle Mass and/or Reducing Fat Gain |
| 01/08/2009 | US20090012141 Composition and Method for Making Oligo-Benzamide Compounds |
| 01/08/2009 | US20090012140 Preparation of Telmisartan Salts with Improved Solubility |
| 01/08/2009 | US20090012139 Amino-5-[4-(difluoromethoxy) phenyl]-5-phenylimidazolone compounds for the inhibition of beta-secretase |
| 01/08/2009 | US20090012138 such as 4-naphthalen-1-ylmethyl-4,5-dihydro-1H-imidazole, useful for the treatment of depression, anxiety, bipolar disorder, schizophrenia, Parkinson's disease, Alzheimer's disease, epilepsy, migraine, hypertension, substance abuse, metabolic, cardiovascular and attention deficit disorder |
| 01/08/2009 | US20090012137 Antmicrobial and radioprotective compounds |
| 01/08/2009 | US20090012136 Unit dose formulations and methods of treating and preventing thrombosis with thromboxane receptor antagonists |
| 01/08/2009 | US20090012134 Arylsulfonyl Benzofused Heterocycles as 5-Ht2a Antagonists |
| 01/08/2009 | US20090012133 Polymorphic Form of -Acetic Acid |
| 01/08/2009 | US20090012132 Pharmaceutical Package |
| 01/08/2009 | US20090012131 4-oxy-n-[1,3,4]-thiadiazol-2-yl-benzene sulfonamides, pharmaceutical compositions and methods for their therapeutic use |
| 01/08/2009 | US20090012130 Strategies for Designing Drugs that Target the Sir2 Family of Enzymes |
| 01/08/2009 | US20090012129 Novel biaromatic compounds that modulate ppar-receptors |
| 01/08/2009 | US20090012128 Microbicidal agent and microbicidal composition |
| 01/08/2009 | US20090012127 Thiophene-2-Carboxamide Derivatives as Alpha 7 Nicotinic Receptor Modulators |
| 01/08/2009 | US20090012126 Certain chemical entities, compositions, and methods |
| 01/08/2009 | US20090012125 Piperidine Derivatives, Their Process for Preparation, Their Use as Therapeutic Agents and Pharmaceutical Compositions Containing Them |
| 01/08/2009 | US20090012124 4-(2,6-dichloro-benzoylamino)-1H-pyrazole-3-carboxylic acid piperidin-4-ylamide acid addition salts as kinase inhibitors |
| 01/08/2009 | US20090012123 Protective Agent for Retinal Neuronal Cell Comprising Indazole Derivative as Active Ingredient |
| 01/08/2009 | US20090012122 N-aroyl cyclic amine derivatives as orexin receptor antagonists |
| 01/08/2009 | US20090012121 Polymorphs of fexofenadine hydrochloride |
| 01/08/2009 | US20090012120 Synthesis of N-heterocycles, beta-amino acids, and allyl amines via aza-payne mediated reaction of ylides and hydroxy aziridines |
| 01/08/2009 | US20090012119 Fluoroalkylpyrrolidine derivative |
| 01/08/2009 | US20090012118 Kynurenic Acid Amide Derivatives as Nr2b Receptor Antagoni |
| 01/08/2009 | US20090012117 Bicyclic derivatives as modulators of ion channels |
| 01/08/2009 | US20090012116 Muscarinic Receptor Antagonists |
| 01/08/2009 | US20090012115 Use of tp modulators for the treatment of cardiovascular disorders in aspirin sensitive and other populations |
| 01/08/2009 | US20090012114 Cyclohepta[B]Pyridine-3-Carbonylguanidine Derivative and Pharmaceutical Product Containing Same |
| 01/08/2009 | US20090012113 Administering rifaximin to the subject |
| 01/08/2009 | US20090012112 Alpha 1A-adrenoceptor antagonists |
| 01/08/2009 | US20090012111 Crystalline polymorph of 7-ethyl-10-hydroxycamptothecin |
| 01/08/2009 | US20090012110 Morphine compounds for pharmaceutical compositions |
| 01/08/2009 | US20090012109 Cyclopamine analogs |
| 01/08/2009 | US20090012108 Salt of 4-[[4-[[4-(2-cyanoethenyl)-2,6-dimethylphenyl]amino]-2-pyrimidinyl]amino]benzonitrile |
| 01/08/2009 | US20090012107 Antiviral Compounds and Methods of Using Thereof |
| 01/08/2009 | US20090012106 Methods, compositions, and kits for organ protection during systemic anticancer therapy |
| 01/08/2009 | US20090012105 Combination of Mtor Inhibitor and Antipolate Compound |
| 01/08/2009 | US20090012104 Inhibitors of 5'-Methylthioadenosine Phosphorylase and 5'-Methylthioadenosine/S-Adenosylhomocysteine Nucleosidase |
| 01/08/2009 | US20090012103 Substituted heterocyclic compounds |
| 01/08/2009 | US20090012102 Imidazo[1,2-C]Pyrimidinylacetic Acid Derivatives |
| 01/08/2009 | US20090012101 Mucarinic Agonists and Methods of Use Thereof |
| 01/08/2009 | US20090012099 Novel Compounds |
| 01/08/2009 | US20090012098 5-ht1a receptor subtype agonist |
| 01/08/2009 | US20090012097 Polycyclic 1,2,3,4-Tetrahydro-Isoquinoline Derivatives and Compositions Comprising Them As Ppar Modulators |
| 01/08/2009 | US20090012096 Pharmaceutical composition for reducing the area of myocardial infarction and its use |
| 01/08/2009 | US20090012095 Human n-type calcium channel blockers |
| 01/08/2009 | US20090012094 e.g. tert-butyl 2-(4-(2-(4-(2-(diethylamino)ethoxy)phenylamino)pyrimidin-5-yl)-2-fluorobenzamido)acetate; C-kit kinase receptor or stem cell factor inhibitors; asthma allergic sinusitis and rhinitis, atopic and allergic dermatitis, allergic contact rheumatoid arthritis, multiple sclerosis, lupus etc. |
| 01/08/2009 | US20090012093 Receptor Function Regulator |
| 01/08/2009 | US20090012092 Hiv Inhibiting 1,2,4-Triazin-6-One Derivatives |